about
Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localizationTumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signalingScreening for glycosylphosphatidylinositol (GPI)-dependent cell wall proteins in Saccharomyces cerevisiae.Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCNHomozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneysThe folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell developmentFolliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulationThe von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure.Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1α/ERRα.Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma.Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling.Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.SPARC expression in primary human renal cell carcinoma: upregulation of SPARC in sarcomatoid renal carcinoma.Transfer of the von Hippel-Lindau gene to neuronal progenitor cells in treatment for Parkinson's disease.Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis.H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC IsotypesMicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation.Bilateral testicular tumors in androgen insensitivity syndromeComprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parametersGene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinomaA three-gene expression signature model to predict clinical outcome of clear cell renal carcinomaDetection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau diseaseReview of hereditary leiomyomatosis renal cell carcinoma with focus on clinical and pathobiological aspects of renal tumorsBHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genesEditorial Comment to Annexin A1 expression is correlated with malignant potential of renal cell carcinomaFolliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseRBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review
P50
Q24324012-D43395CC-6B1D-448C-B7C0-AB2CE7E531D1Q24329165-85B2C98A-78D1-43F4-B408-5B08368ADF02Q27936559-2D2E7EC1-6574-42BA-B2FA-690D7A871890Q28506632-48887D99-5A27-4431-8233-FDDF49F2A66BQ28508427-DB6E3ACF-E7F9-4340-9049-E1E87B1C1D61Q28513499-86040E65-FC54-4C09-8839-C6E67F890FE9Q28587887-D4FBD008-2D1B-47D8-8089-36A026112E57Q30578909-A4FECB18-FB66-4666-A950-1AEF752F19D6Q34307302-533D208C-F5AF-4A67-94C0-66201BC7C2B0Q34517945-85A5223F-239C-4BF9-9675-62C2C9879DE5Q34785861-972088BB-CA4C-4738-9F4B-74F031536DB1Q35279496-5CC0CF58-A048-48A6-A890-B04B61801368Q36832543-45D21390-801A-4A9A-A89A-3D10EC3D809AQ36891685-6013427A-1C3A-4458-BAAA-D805BCCAC9BDQ38647953-840ED002-B7CB-496B-B699-40AB57B2AE63Q38725502-60456E14-88BD-41FE-A6DF-F030AAF99C9EQ40296387-501316BB-D0BF-48FA-825C-A5849B67065DQ40469630-99A71B97-52AA-45ED-AA5C-D7F6600CCAF3Q40519705-E5FE5F8C-8F38-4589-9289-411E8C3EFD6EQ43779201-6E1E33B1-3E6D-4022-84FC-3DCBC193955EQ44571917-CCFB82FA-46DF-46DC-88EB-665D50A449DDQ44790615-DF4BF22B-086E-4F83-B901-FF2CAB3FE160Q51212780-D4C18F95-EF27-4785-A53F-2AE0A8B30730Q51241419-69AA06F7-000E-421D-B023-EB94EFAC70F5Q55043368-F47F0CF9-0CC1-4756-A6BE-7140558F0C99Q55216400-6003EF09-9FE1-4CBC-A41A-FCE7A1D58603Q58323654-B5EDA4F5-EAB1-439E-90DD-3ED0265DB98DQ64930717-DFD9FBAF-9580-41B1-9C9D-0F467AED16ACQ64954495-CC676813-46F9-4C7F-9E78-EA5AB4C865D5Q73362401-01E7A239-A6AC-4304-AF13-9106E39822D7Q77841215-D7C51E6C-7460-410E-9CEB-4E984C618903Q81342868-2D423F99-203F-413F-AA98-28CB37CB378AQ81436934-057A7FCE-69A2-408B-B7DC-742080D8CF78Q83185578-63D716D7-76E6-4A4A-BFEA-DD79EC79A795Q88000544-C698032A-B5C5-4F08-BF29-967B79F5B4A7Q88692046-76973676-732D-4183-B2C0-786183A88434Q91015943-2FCC6E58-4FF1-41A1-8C4E-BE40DB6D1B6EQ91062020-9822C9C7-A736-4C1E-BDD3-B1C6ADD64F5CQ91674803-56A59130-8C86-4B6D-A8F4-5BCF33E483A4Q92599969-69AC3FB6-AEC0-4F79-AD15-BB0FFFBE5855
P50
description
researcher ORCID ID = 0000-0002-5308-6683
@en
wetenschapper
@nl
name
Masaya Baba
@ast
Masaya Baba
@en
Masaya Baba
@es
Masaya Baba
@nl
type
label
Masaya Baba
@ast
Masaya Baba
@en
Masaya Baba
@es
Masaya Baba
@nl
prefLabel
Masaya Baba
@ast
Masaya Baba
@en
Masaya Baba
@es
Masaya Baba
@nl
P106
P1153
7402885558
P31
P496
0000-0002-5308-6683